XML 37 R28.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SHAREHOLDERS' EQUITY (Tables)
6 Months Ended
Jun. 30, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Assumptions Used to Estimate Fair Value
 
Six months ended June 30,
 
2024
   
2023
         
Risk free interest
4.35% - 4.56%
   
3.57% - 4.08%
Dividend yields
0%
   
0%
Volatility
47.9% - 49.0%
   
52.77% - 53.71%
Expected term (in years)
3.83
   
3.88 – 3.92
Schedule of Stock Option Activity
   
Number of options
   
Weighted-
average
exercise
price
   
Weighted-
average
remaining
contractual
term
(in years)
   
 
 
Aggregate
intrinsic value
(in thousands)
 
                         
Outstanding at January 1, 2024
   
5,679,775
   
$
6.9
     
4.2
   
$
817
 
Granted
   
280,000
   
$
5.8
                 
Exercised
   
(76,875
)
 
$
6.4
                 
Forfeited and cancelled
   
(337,875
)
 
$
10.5
                 
                                 
Outstanding as of June 30, 2024
   
5,545,025
   
$
6.7
     
4.0
   
$
-
 
                                 
Exercisable as of June 30, 2024
   
2,219,608
   
$
7.0
     
3.1
   
$
6
 
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]
   
Six months ended
 
   
June 30,
 
   
2024
   
2023
 
             
Cost of revenue of products
 
$
136
   
$
76
 
Cost of revenue of services
   
164
     
94
 
Research and development expenses, net
   
356
     
312
 
Selling and marketing expenses
   
305
     
163
 
General and administrative expenses
   
2,927
     
469
 
                 
   
$
3,888
   
$
1,114